While awaiting the clinical results of potentially promising drugs in the treatment of Alzheimer’s disease, the Trecento AM team comments on Challenges the decision of Agnès Buzyn to change the patient care path. “Even if the drug reassures, the challenge today is to change attitudes by ending the only drug to highlight the (…)” Read…
Christophe Pouchoy, Managing Director and General Manager, co-manager of the Trecento Santé fund, answered Pharmaceutical magazine’s questions about the growth and profitability of the pharmaceutical and biotech sector. He also explained the favorable impact for the US tax reform sector. “For big pharma, which has a significant turnover in the US market, the largest in…
Alice Lhabouz, CEO and Founder of Trecento AM, explains in Funds Magazine the success of Thematic Management and of its Trecento Robotics Fund. “Robotics is a segment that has been mainly invested by private equity for the last ten years, and these investors, who have spent seven to ten years preparing for the initial public offering…
Christophe Pouchoy, Manager of the Trecento Santé fund, answered questions of the magazine Pharmaceutiques about the healthcare industry and its prospects. “In 2017, the amount of transactions should reach € 412 billion in annualized against € 468 billion in 2016. Even if the fiscal conditions became harder in the United States, with the restrictions in…
Alice Lhabouz, CEO of Trecento AM, highlighted in PME Magazine (Swiss magazine) the potential attractiveness and yield that the robotics investment universe can offer. “The demographic and environmental shocks as well as the search for innovation and competitiveness by companies accelerate the rise of robotization and artificial intelligence, likely catalysts of the fourth industrial revolution.…
From tool-machines to robots, technologic advances are terrific. Thematic funds or direct share investment: the choice is attractive […] – – Read the entire article here. This article is only available in French. — –
